Memorial Sloan-Kettering

New York, New York 10065

Use our guide to learn which trials are right for you!

We've found
20 trials
at this facility
Leukemia Clinical Trial
Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients
Status: Enrolling, Phase I, II
Updated: 12/15/2014
mi
from
New York, NY
Click here to add this to my saved trials
Adenovirus Clinical Trial
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
Status: Enrolling
Updated: 2/25/2016
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Clinical Trial
Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
CAB-AXL-ADC Safety and Efficacy Study in Patients With Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Muscle-invasive Urothelial Cancer of the Bladder Clinical Trial
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of GNS561 in Patients With Liver Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Transfusion Related Acute Lung Injury Clinical Trial
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Adenovirus Clinical Trial
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects
Status: Enrolling, Phase I
Updated: 2/9/2016
mi
from
New York, NY
Click here to add this to my saved trials
Amyloidosis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
NF type1 With Inoperable Plexiform Neurofibromas Clinical Trial
An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials